BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19154459)

  • 1. Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.
    See WA; Zhang G; Chen F; Cao Y; Langenstroer P; Sandlow J
    BJU Int; 2009 Jun; 103(12):1714-20. PubMed ID: 19154459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
    Chen F; Zhang G; Cao Y; Hessner MJ; See WA
    J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
    J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
    Chen F; Zhang G; Cao Y; Payne R; See WA
    J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; See WA
    J Urol; 2013 Oct; 190(4):1398-403. PubMed ID: 23583857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
    Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
    J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Johnson B; See WA
    J Urol; 2013 Apr; 189(4):1541-6. PubMed ID: 23041342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.
    Chen F; Zhang G; Cao Y; Wakim B; See WA
    J Urol; 2013 Mar; 189(3):1104-9. PubMed ID: 22999999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
    J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking.
    Chen F; Zhang G; Iwamoto Y; See WA
    BMC Urol; 2005 May; 5():8. PubMed ID: 15890073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
    Dong Xda E; Ito N; Lotze MT; Demarco RA; Popovic P; Shand SH; Watkins S; Winikoff S; Brown CK; Bartlett DL; Zeh HJ
    J Immunother; 2007 Sep; 30(6):596-606. PubMed ID: 17667523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibition: a potential mechanism for increasing the efficacy of bacillus calmette-guerin immunotherapy for bladder cancer.
    Dovedi SJ; Kirby JA; Atkins H; Davies BR; Kelly JD
    J Urol; 2005 Jul; 174(1):332-7; discussion 337. PubMed ID: 15947685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro.
    Barqasho B; Nowak P; Abdurahman S; Walther-Jallow L; Sönnerborg A
    J Gen Virol; 2010 Jul; 91(Pt 7):1800-9. PubMed ID: 20200191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signalling.
    Miyazaki J; Kawai K; Oikawa T; Johraku A; Hattori K; Shimazui T; Akaza H
    BJU Int; 2006 Apr; 97(4):860-4. PubMed ID: 16536788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
    Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
    Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic cells induce HMGB1 release from melanoma cell lines.
    Ito N; DeMarco RA; Mailliard RB; Han J; Rabinowich H; Kalinski P; Stolz DB; Zeh HJ; Lotze MT
    J Leukoc Biol; 2007 Jan; 81(1):75-83. PubMed ID: 16968820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical bacillus calmette-guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer.
    Fontana D; Bellina M; Galietti F; Scoffone C; Cagnazzi E; Guercio S; Cappia S; Pozzi E
    J Urol; 1999 Jul; 162(1):225-30. PubMed ID: 10379791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Yu DS; Wu CL; Ping SY; Keng C; Shen KH
    Kaohsiung J Med Sci; 2015 Aug; 31(8):391-7. PubMed ID: 26228277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.